Tsuyoshi Ito
Directeur/Membre du Conseil chez RIVERFIELD, Inc.
Profil
Tsuyoshi Ito currently works at Beyond Next Ventures, Inc., as CEO & Managing Partner from 2014, RIVERFIELD, Inc., as Director, Novenine, Inc., as Outside Director, and Regional Fish Institute, Ltd., as Outside Director.
Mr. Ito also formerly worked at CYBERDYNE, Inc., as Outside Director, Cyfuse Biomedical KK, as Outside Director, Quantum Biosystems, Inc., as Outside Director from 2013 to 2014, and Spiber, Inc., as Outside Director.
Mr. Ito received his graduate degree from Tokyo Institute of Technology.
Postes actifs de Tsuyoshi Ito
| Sociétés | Poste | Début |
|---|---|---|
RIVERFIELD, Inc.
 RIVERFIELD, Inc. Medical SpecialtiesHealth Technology RIVERFIELD, Inc. engages in the research, development, and manufacture of medical equipment systems. It specializes in the production and commercialization of surgical robotic support systems for the medical and healthcare industries. The firm also offers endoscopic operation systems. The company was founded on May 20, 2014 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | - |
Beyond Next Ventures, Inc.
 Beyond Next Ventures, Inc. Investment ManagersFinance Beyond Next Ventures, Inc. (Beyond Next Ventures) is an Independent Venture Capital firm founded in 2014. Beyond Next Ventures, Inc. is headquartered in Tokyo. | Private Equity Investor | 12/08/2014 |
Novenine, Inc.
 Novenine, Inc. Medical/Nursing ServicesHealth Services Novenine, Inc. provides oral healthcare services and offers healthcare management systems. Novenine was founded in 2018 by Akira Takeyama. Akira Takeyama has been the CEO since 2018. | Directeur/Membre du Conseil | - |
Regional Fish Institute, Ltd.
 Regional Fish Institute, Ltd. Packaged SoftwareTechnology Services Regional Fish Institute, Ltd. is a Japanese company that focuses on innovation in the aquatic industry through high-speed breeding and smart aquaculture. The company is based in Kyoto, Japan. The company aims to contribute to the industry and create new industries in the region. The company was founded in 2019 by Tadanori Umekawa, Masato Kinoshita. Tadanori Umekawa has been the CEO since 2019. | Directeur/Membre du Conseil | - |
Anciens postes connus de Tsuyoshi Ito
| Sociétés | Poste | Fin |
|---|---|---|
Quantum Biosystems, Inc.
 Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Directeur/Membre du Conseil | 01/07/2014 |
| CYFUSE BIOMEDICAL K.K. | Directeur/Membre du Conseil | - |
| CYBERDYNE INC. | Directeur/Membre du Conseil | - |
Spiber, Inc.
 Spiber, Inc. Miscellaneous Commercial ServicesCommercial Services Spiber, Inc. provides research, development, and production of synthetic spider silk. It specializes in the production of artificial spider silk using synthesized genes which persuade bacteria to produce fibroin, a structural protein found in spider silk. The firm analyzes the mechanism of the bimolecular structure of spider silk protein using bioinformatics. The company was founded on September 26, 2007 and is headquartered in Tsuruoka, Japan. | Directeur/Membre du Conseil | - |
Formation de Tsuyoshi Ito
| Tokyo Institute of Technology | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CYFUSE BIOMEDICAL K.K. | Health Technology |
| CYBERDYNE INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Health Technology |
Spiber, Inc.
Spiber, Inc. Miscellaneous Commercial ServicesCommercial Services Spiber, Inc. provides research, development, and production of synthetic spider silk. It specializes in the production of artificial spider silk using synthesized genes which persuade bacteria to produce fibroin, a structural protein found in spider silk. The firm analyzes the mechanism of the bimolecular structure of spider silk protein using bioinformatics. The company was founded on September 26, 2007 and is headquartered in Tsuruoka, Japan. | Commercial Services |
RIVERFIELD, Inc.
RIVERFIELD, Inc. Medical SpecialtiesHealth Technology RIVERFIELD, Inc. engages in the research, development, and manufacture of medical equipment systems. It specializes in the production and commercialization of surgical robotic support systems for the medical and healthcare industries. The firm also offers endoscopic operation systems. The company was founded on May 20, 2014 and is headquartered in Tokyo, Japan. | Health Technology |
Beyond Next Ventures, Inc.
Beyond Next Ventures, Inc. Investment ManagersFinance Beyond Next Ventures, Inc. (Beyond Next Ventures) is an Independent Venture Capital firm founded in 2014. Beyond Next Ventures, Inc. is headquartered in Tokyo. | Finance |
Novenine, Inc.
Novenine, Inc. Medical/Nursing ServicesHealth Services Novenine, Inc. provides oral healthcare services and offers healthcare management systems. Novenine was founded in 2018 by Akira Takeyama. Akira Takeyama has been the CEO since 2018. | Health Services |
Regional Fish Institute, Ltd.
Regional Fish Institute, Ltd. Packaged SoftwareTechnology Services Regional Fish Institute, Ltd. is a Japanese company that focuses on innovation in the aquatic industry through high-speed breeding and smart aquaculture. The company is based in Kyoto, Japan. The company aims to contribute to the industry and create new industries in the region. The company was founded in 2019 by Tadanori Umekawa, Masato Kinoshita. Tadanori Umekawa has been the CEO since 2019. | Technology Services |